Eldred Rock Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
165,219
+69,184
| +72% | +$4.78M | 3.47% | 13 |
|
|
2025
Q1 | $8.81M | Buy |
96,035
+20,184
| +27% | +$1.85M | 2.69% | 24 |
|
|
2024
Q4 | $6.87M | Sell |
75,851
-15,323
| -17% | -$1.39M | 2.36% | 24 |
|
|
2024
Q3 | $10.9M | Buy |
91,174
+49,484
| +119% | +$5.89M | 3.63% | 13 |
|
|
2024
Q2 | $5.95M | Buy |
41,690
+10,720
| +35% | +$1.53M | 2.49% | 20 |
|
|
2024
Q1 | $3.98M | Sell |
30,970
-2,683
| -8% | -$344K | 2.17% | 18 |
|
|
2023
Q4 | $3.48M | Buy |
+33,653
| New | +$3.48M | 2.22% | 17 |
|